RU2018147077A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018147077A3 RU2018147077A3 RU2018147077A RU2018147077A RU2018147077A3 RU 2018147077 A3 RU2018147077 A3 RU 2018147077A3 RU 2018147077 A RU2018147077 A RU 2018147077A RU 2018147077 A RU2018147077 A RU 2018147077A RU 2018147077 A3 RU2018147077 A3 RU 2018147077A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562172339P | 2015-06-08 | 2015-06-08 | |
| US15/176,422 | 2016-06-08 | ||
| US15/176,422 US10285963B2 (en) | 2015-06-08 | 2016-06-08 | Combination of metabolic bio-energetic and nutra-epigentic regulators, nutraceutical compounds in conventional and nanotechnologies combination to revert and prevent the chronic damage accelerated cellular senescence produced by diabetes and other degenerative chronic complex diseases |
| MXMX/A/2017/007448 | 2017-06-07 | ||
| MX2017007448A MX365886B (es) | 2015-06-08 | 2017-06-07 | Combinación de reguladores metabólicos bioenergéticos y nutra-epigenéticos, compuestos nutracéuticos en combinaciones convencionales y nanotecnológicas para revertir y prevenir la senescencia celular acelerada por daño crónico producida por diabetes y otras enfermedades complejas crónico-degenerativas. |
| PCT/MX2017/000061 WO2017213486A2 (es) | 2016-06-08 | 2017-06-08 | Combinación de reguladores metabólicos bioenergéticos y nutra-epigenéticos, compuestos nutracéuticos en combinaciónes convencionales y nanotecnológicas para revertir y prevenir la sesencencia celular acelerada por daño crónico producida por diabetes y otras enfermedades complejas crónico-degenerativas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018147077A RU2018147077A (ru) | 2020-07-10 |
| RU2018147077A3 true RU2018147077A3 (enExample) | 2020-09-21 |
| RU2749950C2 RU2749950C2 (ru) | 2021-06-21 |
Family
ID=57450744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018147077A RU2749950C2 (ru) | 2015-06-08 | 2017-06-08 | Применение композиции, состоящей из аминокислот глицина, аргинина, цистеина и ресвератрола, для снижения тяжести диабета и высокого содержания жира в организме, холестерина, мочевой кислоты, глюкозы в крови и ускоренного старения у животных и человека |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10285963B2 (enExample) |
| JP (1) | JP2019521184A (enExample) |
| CN (1) | CN109890369B (enExample) |
| BR (1) | BR112018075395A2 (enExample) |
| CA (1) | CA3027048A1 (enExample) |
| ES (1) | ES2988151T3 (enExample) |
| MX (1) | MX365886B (enExample) |
| RU (1) | RU2749950C2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3470060B1 (en) * | 2016-06-08 | 2024-07-31 | Astudillo De La Vega, Horacio | Composition comprising resveratrol, glycine, arginine and cysteine for use in treating metabolic syndrome |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006273834A (ja) * | 2004-06-28 | 2006-10-12 | Kao Corp | Ampk活性化剤 |
| US7709539B2 (en) * | 2004-08-11 | 2010-05-04 | Chang Gung University | Therapeutic use of resveratrol for hyperglycemia |
| ITPD20050224A1 (it) * | 2005-07-19 | 2007-01-20 | Actimex Srl | Composizioni contenenti micronutrienti aventi in particolare attivita' antiossidante e loro impiego |
| WO2007035612A2 (en) * | 2005-09-16 | 2007-03-29 | Ordway Research Institute, Inc. | Polyphenol conjugates as rgd-binding compounds and methods of use |
| JPWO2008143182A1 (ja) * | 2007-05-17 | 2010-08-05 | 株式会社カネカ | 甘草ポリフェノールを含有する組成物 |
| JP5594819B2 (ja) * | 2009-12-22 | 2014-09-24 | キリンホールディングス株式会社 | 脂質代謝改善用組成物 |
| JP2012041296A (ja) * | 2010-08-19 | 2012-03-01 | Medience Corp | 血管内皮機能改善剤、一酸化窒素産生促進剤、及び飲食品 |
| EP3466418A1 (en) * | 2011-07-15 | 2019-04-10 | NuSirt Sciences, Inc. | Compositions and methods for modulating metabolic pathways |
-
2016
- 2016-06-08 US US15/176,422 patent/US10285963B2/en active Active
-
2017
- 2017-06-07 MX MX2017007448A patent/MX365886B/es active IP Right Grant
- 2017-06-08 ES ES17810608T patent/ES2988151T3/es active Active
- 2017-06-08 BR BR112018075395-5A patent/BR112018075395A2/pt not_active Application Discontinuation
- 2017-06-08 CN CN201780046806.6A patent/CN109890369B/zh active Active
- 2017-06-08 JP JP2019517750A patent/JP2019521184A/ja active Pending
- 2017-06-08 RU RU2018147077A patent/RU2749950C2/ru active
- 2017-06-08 CA CA3027048A patent/CA3027048A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2988151T3 (es) | 2024-11-19 |
| CN109890369B (zh) | 2022-04-29 |
| JP2019521184A (ja) | 2019-07-25 |
| BR112018075395A2 (pt) | 2019-04-02 |
| US10285963B2 (en) | 2019-05-14 |
| CA3027048A1 (en) | 2017-12-14 |
| MX365886B (es) | 2019-06-19 |
| CN109890369A (zh) | 2019-06-14 |
| US20160354331A1 (en) | 2016-12-08 |
| RU2018147077A (ru) | 2020-07-10 |
| RU2749950C2 (ru) | 2021-06-21 |
| MX2017007448A (es) | 2018-09-10 |